American Well (AMWL) Stock Price, News & Analysis

Company Overview

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration. In addition, American Well provides white-label solutions that allow hospitals, health systems and health plans to brand and manage their own telehealth services. Its suite of services also extends to medical device integration for real-time monitoring, population health analytics and specialized telepsychiatry, enabling partners to deliver comprehensive care remotely.

Founded in 2006 by Dr. Ido Schoenberg and brothers Roni and Roy Schoenberg, American Well pioneered the digital health sector by forging early partnerships with leading health systems and insurers in the United States. Over time, the company has expanded its footprint beyond North America, collaborating with healthcare organizations and technology partners in Europe, Asia and Latin America. Its platform is designed to comply with regional privacy and data security regulations, including HIPAA in the U.S. and GDPR in Europe.

Under the leadership of CEO Ido Schoenberg, American Well has focused on advancing telehealth interoperability, user experience and clinical quality. The executive team includes seasoned professionals from healthcare, technology and regulatory backgrounds, supporting a mission to make telemedicine an integral part of mainstream care delivery. As telehealth adoption grows globally, American Well continues to invest in platform enhancements, strategic partnerships and new care modalities to meet evolving provider and patient needs.

Key Stats

• Today's Range: $9.21 to $9.67
• 50-Day Range: $5.92 to $9.74
• 52-Week Range: $3.71 to $9.96
• Volume: 79,854 shs
• Average Volume: 79,607 shs
• Market Capitalization: $153.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.20
• Consensus Rating: Hold

American Well Stock Analysis - MarketRank™

American Well scored higher than 43% of companies evaluated by MarketBeat, and ranked 549th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

American Well has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.

Downside Risk

American Well has a consensus price target of $7.20, representing about 22.3% downside from its current price of $9.27.

Amount of Analyst Coverage

American Well has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for American Well are expected to grow in the coming year, from ($2.68) to ($1.68) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of American Well is -1.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of American Well is -1.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

American Well has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.29% of the float of American Well has been sold short.

Short Interest Ratio / Days to Cover

American Well has a short interest ratio ("days to cover") of 1.52, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in American Well has recently decreased by 6.58%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

American Well does not currently pay a dividend.

Dividend Growth

American Well does not have a long track record of dividend growth.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: -0.12

News Sentiment

American Well has a news sentiment score of -0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for American Well this week, compared to 2 articles on an average week.

MarketBeat Follows

2 people have added American Well to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 2.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, American Well insiders have sold 5,339.91% more of their company's stock than they have bought. Specifically, they have bought $4,938.00 in company stock and sold $268,623.00 in company stock.

Percentage Held by Insiders

12.84% of the stock of American Well is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

56.05% of the stock of American Well is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/05/2026
• Today: 7/04/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Business Services
• Current Symbol: NYSE:AMWL
• CIK: 1393584
• Web: amwell.com
• Phone: 617-204-3500
• Fax: N/A
• Employees: 1,040
• Year Founded: 2006

Price Target and Rating

• Average Price Target for American Well: $7.20
• High Price Target: $9.00
• Low Price Target: $5.00
• Potential Upside/Downside: -22.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($5.42)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$95.70 million
• Net Margins: -37.02%
• Pretax Margin: -36.19%
• Return on Equity: -32.11%
• Return on Assets: -24.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.09
• Quick Ratio: 3.08

Sales & Book Value

• Annual Sales: $249.32 million
• Price / Sales: 0.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.97 per share
• Price / Book: 0.62

Miscellaneous

• Outstanding Shares: 16,550,000
• Free Float: 14,427,000
• Market Cap: $153.34 million
• Optionable: Optionable
• Beta: 1.69